Medical devices, healthcare technology and the business of care
PMA approval · P240039

SetPoint System

SetPoint Medical · Decision date Jul 30, 2025

FDA DECISIONP240039

What did the FDA approve?

FDA records P240039 as an original PMA application. The recorded decision is approval, dated Jul 30, 2025.

FDA approval order statement

The SetPoint System is indicated for use in the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response, loss of response, or intolerance to one or more biological or targeted synthetic disease modifying antirheumatic drugs (b/tsDMARDs).
Regulatory pathway
Original PMA
Clinical specialty
Neurology
Decision date
Jul 30, 2025

FDA source record

Regulatory record facts

Identifier
P240039
Regulatory pathway
Premarket approval application
Product code
SFJ
Decision code
APPR
Decision date
Jul 30, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Vagus nerve stimulator for rheumatoid arthritis.

Product code
SFJ
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P240039 received

    Application receipt date recorded by FDA.

  2. P240039 · FDA decision

    APPR

  3. P240039/S003 · Related supplement

    Charger SetPoint System

Timeline entries are records held by MedtechLedger for P240039. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P240039

Product / regulatory recordCompanyPathwayDecision dateSource
SetPoint MedicalPMA supplementOct 16, 2026FDA
SetPoint SystemP240039/S004
SetPoint MedicalPMA supplementOct 29, 2026FDA

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

SetPoint Medical

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
25101 Rye Canyon Loop, Valencia, CA, 91355

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records